Spontaneous Urticaria
📧 Sign up to get email alerts when something new happens for Spontaneous Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine [Phase 2]
Phase 2 clinical trial evaluating rilzabrutinib for chronic spontaneous urticaria in patients who remain symptomatic despite H1 antihistamin…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension. [Phase 3]
Phase 3b study evaluating remibrutinib vs placebo with omalizumab as active control in adult chronic spontaneous urticaria, with an optional…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of Efficacy and Safety of TLL-018 in CSU Participants [Phase 3]
Phase 3 study update on the efficacy and safety of TLL-018 in chronic spontaneous urticaria (CSU) is currently active, not recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of MG-K10 in Chronic Spontaneous Urticaria [Phase 3]
This is an update on a Phase 3 clinical trial evaluating MG-K10 for chronic spontaneous urticaria, which is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria [Phase 2, Phase 3]
An ongoing Phase 2/3 clinical trial evaluating the efficacy and safety of ICP-332 in people with chronic spontaneous urticaria; recruitment …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of EDP-978 in healthy adu…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Remibrutinib in Real-world Clinical Practice
An update indicates that a real-world clinical trial of remibrutinib for chronic spontaneous urticaria is currently recruiting, sponsored by…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines [Phase 2]
Phase 2 clinical trial evaluating Lesigercept for adults with chronic spontaneous urticaria inadequately controlled by H1 antihistamines; cu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up [Phase 3]
Phase 3, double-blind, randomized, placebo-controlled trial to assess the efficacy, pharmacokinetics, and safety of LOU064 in adolescents (1…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria
This study aims to describe real-world effectiveness, safety, and patterns of use of dupilumab in patients with chronic spontaneous urticari…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. [Phase 2]
Pfizer is conducting a Phase 2 trial to evaluate ritlecitinib as a potential treatment for chronic spontaneous urticaria in adults; the stud…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU) [Phase 2]
A Phase 2 clinical trial evaluating CM512 injection for chronic spontaneous urticaria is currently recruiting.
-
CLINICAL_TRIALS other · 2026-04-09Clinical Trial Update: Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU) [Phase 2]
This is an administrative update on the Phase 2b trial of EVO756 for chronic spontaneous urticaria, noting the study is currently active but…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria [Phase 3]
A Phase 3 long-term efficacy and safety extension study of Barzolvolimab for chronic spontaneous urticaria is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of remibrutinib (LOU064) in chronic urticaria, including chronic spontaneous …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) [Phase 3]
This update notes that a Phase 3 trial of Barzolvolimab for chronic spontaneous urticaria is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria [Phase 3]
A Phase 3 clinical trial evaluating Barzolvolimab for chronic spontaneous urticaria is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
This document summarizes an ongoing longitudinal observational study of patients undergoing therapy for IMISC (NCT03661866) across several i…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria [Phase 2]
Phase 2 clinical trial update reporting efficacy and safety data for povorcitinib in adults with chronic spontaneous urticaria; results comp…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib [Phase 3]
An extension Phase 3 study evaluating long-term efficacy, safety, and tolerability of remibrutinib in chronic spontaneous urticaria patients…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension. [Phase 3]
This document describes a Phase 3b trial evaluating remibrutinib versus placebo with omalizumab as an active control in adults with chronic …
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines [Phase 3]
Phase 3 clinical trial evaluating remibrutinib versus dupilumab at early timepoints in adults with chronic spontaneous urticaria inadequatel…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
A real-world study evaluating remibrutinib for chronic spontaneous urticaria, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Effects of Diet and Oxidative Stress on Disease Severity and Response to Omalizumab in Chronic Spontaneous Urticaria
This clinical trial update indicates ongoing enrollment for a study investigating how diet and oxidative stress affect disease severity and …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
This ClinicalTrials.gov entry describes an observational study evaluating Omlyclo®, an omalizumab biosimilar, in patients with chronic spont…